Liver Cancer Trial, Recruiting NCT06905262 Sponsor: National Cancer Institute, Naples Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT06905262
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with primary liver cancer (HCC) or another type of cancer, confirmed by a tissue diagnosis from an approved medical facility
  • People aged 18 years or older (for those with a cancer diagnosis)
  • People who are able to sign a consent form agreeing to follow the requirements of the trial
  • In some cases, people whose tissue samples are already stored in a pathology unit or biological bank may be included without needing to sign a new consent form, in line with Italian privacy and data protection regulations (confirm with trial site)
  • Healthy volunteers who have never been diagnosed with or treated for any form of cancer during their lifetime
  • Healthy volunteers who are aged 80 years or older
  • Healthy volunteers who are able to sign a consent form agreeing to follow the requirements of the trial

Who may not be able to join:

  • People who are currently taking antibiotics for an ongoing illness
  • Healthy volunteers who have been diagnosed with a pre-cancerous condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Luigi Buonaguro, IRCCS I.N.T. "G. Pascale"

Phone: 08117770587

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Cancer Institute, Naples
Registry
ClinicalTrials.gov
Start date
2 January 2023
Est. completion
30 September 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Identification and classification of the numerical variation; Identification and classification of the different number and identity of antigens; Identification and classification of the number and identity of TuAs

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov